Maravai LifeSciences Holdings, Inc. (MRVI)
NASDAQ: MRVI · Real-Time Price · USD
6.23
-0.02 (-0.32%)
At close: Aug 7, 2026, 4:00 PM EDT
6.30
+0.07 (1.12%)
After-hours: Aug 7, 2026, 7:35 PM EDT
MRVI Market Cap
MRVI has a market cap or net worth of $1.61 billion as of August 7, 2026. Its market cap has increased by 210.41% in one year.
Market Cap
1.61B
Enterprise Value
1.76B
1-Year Change
210.41%
Ranking
Category
Stock Price
$6.23
ChartMarket Cap Chart
Since the IPO on November 20, 2020, MRVI's market cap has decreased from $7.23B to $1.61B, a decrease of -77.76%. That is a compound annual growth rate of -23.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 1.62B | 94.68% |
| Dec 31, 2025 | 831.00M | -39.62% |
| Dec 31, 2024 | 1.38B | -16.38% |
| Dec 29, 2023 | 1.65B | -54.93% |
| Dec 30, 2022 | 3.65B | -66.18% |
| Dec 31, 2021 | 10.80B | 49.29% |
| Dec 31, 2020 | 7.23B | 0.01% |
| Nov 20, 2020 | 7.23B | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| First Tracks Biotherapeutics | 1.60B |
| Maze Therapeutics | 1.55B |
| Innoviva | 1.51B |
| Xencor | 1.50B |
| Vir Biotechnology | 1.50B |
| MoonLake Immunotherapeutics | 1.49B |
| Savara | 1.48B |
| Avalyn Pharma | 1.46B |